The U.S. Department of Veterans Affairs is taking aim at homelessness and its related issues affecting America's veteran ...

President Trump told reporters this week that he would send letters to trading partners in the next week or two setting ...

WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

Merus initially surged on superior interim trial data, while Bicara Therapeutics tanked. Click here to find out why BCAX ...

News Is Out reports that queer-owned brands are addressing challenges from rising tariffs through transparency and community ...

Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further devel ...

India's digital infrastructure development has been a "game-changer", putting the country ahead of most other nations, ...

Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...

Tesla ( TSLA 5.66%) stock has tumbled 22% year to date amid a myriad of business and political headwinds, and Wall Street ...

TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab.